Crinetics Pharmaceuticals (CRNX) Q1 2025 Earnings

27FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.96
-0.91
-0.86
-0.81

Details

Expected EPS
-0.886109
Actual EPS
-0.88
Surprise EPS
0.01
Surprise Percent
+0.69%

Description

Crinetics Pharmaceuticals (CRNX) has reported earnings of -0.88 per share for Q1 2025.

0 Comments

Share your thoughts